Devices, systems, and methods for treating and preventing disease
Devices, systems, and methods configured to treat disease using electrical stimulation and therapeutic agents are disclosed herein. In some embodiments, a device of the present technology comprises a first elongated shaft configured to deliver supplemental nutrition to a patient suffering from dysphagia and a second elongated shaft configured to slidably receive the first elongated shaft. The second elongated shaft can include one or more conductive elements configured to deliver electrical stimulation to nerves at a first treatment site in a pharynx of the patient. In some embodiments, the second elongated shaft includes one or more therapeutic elements carrying a therapeutic agent configured to be positioned at or adjacent a second treatment site with a pooled secretion in the patient's pharynx. The therapeutic agent can be configured to prevent or inhibit colonization of the pooled secretion by one or more pathogens. In some embodiments, the second elongated shaft includes a lumen fluidically coupled to an aperture extending through a sidewall of the elongated shaft. The aperture can be configured to be positioned at or adjacent the second treatment site with the pooled secretion. The lumen and aperture can be configured to transport fluid therethrough along a longitudinal dimension of the device to deliver a therapeutic agent to the second treatment site and/or withdraw the pooled secretion from the second treatment site into the lumen.
1 . A device for delivering an electrical stimulus to nerves proximate a body lumen of a human patient and preventing or reducing aspiration of a substance from the body lumen into an airway of the patient, the device comprising:
a pressure source;
a first elongated shaft;
a second elongated shaft having a proximal portion configured to be electrically coupled to an energy source and fluidically coupled to the pressure source and a distal portion configured to be positioned at or adjacent a treatment site within the body lumen, the second elongated shaft having a sidewall defining a first lumen configured to slidably receive the first elongated shaft therethrough, a second lumen, and an aperture extending radially between the second lumen and an outer surface of the second elongated shaft; and
a conductive element carried by the distal portion of the second elongated shaft and configured to be electrically coupled to the energy source to deliver an electrical stimulus to nerves proximate the body lumen at the treatment site,
wherein, when the first and second elongated shafts are positioned in the body lumen with the conductive element located at or adjacent the treatment site, the aperture is located within a treatment distance of the substance within the body lumen, and
wherein the pressure source is configured to generate negative pressure within the second lumen to draw the substance into the aperture and proximally through the second lumen.
2 . The device of claim 1 , wherein the pressure source is configured to generate positive pressure within the second lumen to transport a fluid including a therapeutic agent distally through the second lumen and the aperture to the substance.
3 . The device of claim 2 , wherein the therapeutic agent is an antimicrobial agent configured to prevent or inhibit colonization of the substance by a pathogen.
4 . The device of claim 1 , wherein the body lumen comprises a pharynx of the patient.
5 . The device of claim 4 , wherein the substance is positioned within a recess of the patient's pharynx.
6 . A device for delivering an electrical stimulus to nerves proximate a pharynx of a human patient and preventing or reducing aspiration of a substance from the pharynx into an airway of the patient, the device comprising:
a pressure source;
an elongated member having a proximal portion configured to be electrically coupled to an energy source and fluidically coupled to a pressure source and a distal portion configured to be positioned at or adjacent a treatment site within the pharynx, the elongated member having a sidewall defining a lumen therethrough and an aperture extending radially between the lumen and an outer surface of the elongated member; and
a conductive element carried by the distal portion of the elongated member and configured to be electrically coupled to the energy source to deliver an electrical stimulus to nerves proximate the pharynx at the treatment site, wherein the aperture is disposed proximal of the conductive element along a longitudinal axis of the elongated member,
wherein, when the elongated member is positioned in the pharynx with the conductive element located at or adjacent the treatment site, the aperture is located within a treatment distance of the substance within the pharynx, and
wherein the pressure source is configured to generate a negative pressure within the lumen to draw the substance into the aperture and proximally through the lumen.
7 . The device of claim 6 , wherein the elongated member comprises a closed distal end.
8 . The device of claim 6 , wherein the substance is positioned within a recess of the patient's pharynx.
9 . The device of claim 6 , wherein the elongated member does not comprise a feeding tube.
10 . The device of claim 6 , wherein the nerves comprise a glossopharyngeal nerve.
11 . The device of claim 6 , wherein the elongated member comprises a therapeutic region at the distal portion, the therapeutic region containing a therapeutic agent configured to prevent or reduce colonization of the substance by a pathogen.
12 . The device of claim 11 , wherein the therapeutic region is configured to release the therapeutic agent when the therapeutic region is in mechanical or fluidic contact with the substance.
13 . A device for delivering an electrical stimulus to nerves proximate a pharynx of a human patient and preventing or reducing aspiration of a substance from the pharynx into an airway of the patient, the device comprising:
an elongated member having a proximal portion configured to be electrically coupled to an energy source and fluidically coupled to a pressure source and a distal portion configured to be positioned at or adjacent a treatment site within the pharynx, the elongated member having a sidewall defining a lumen therethrough and an aperture extending radially between the lumen and an outer surface of the elongated member; and
a conductive element carried by the distal portion of the elongated member and configured to be electrically coupled to the energy source to deliver an electrical stimulus to nerves proximate the pharynx at the treatment site, wherein the aperture is disposed proximal of the conductive element along a longitudinal axis of the elongated member,
wherein, when the elongated member is positioned in the pharynx with the conductive element located at or adjacent the treatment site, the aperture is located within the pharynx adjacent the valleculae and/or pyriform sinuses, and
wherein the pressure source is configured to generate a negative pressure within the lumen to draw the substance from the valleculae and/or pyriform sinuses into the aperture and proximally through the lumen.
14 . The device of claim 13 , wherein the elongated member comprises an open distal end.
15 . The device of claim 13 , wherein the elongated member comprises a closed distal end.
16 . The device of claim 13 , wherein the substance is positioned within a recess of the patient's pharynx.
17 . The device of claim 13 , wherein the elongated member does not comprise a feeding tube.
18 . The device of claim 13 , wherein the nerves comprise a glossopharyngeal nerve.
19 . The device of claim 13 , wherein the elongated member comprises a therapeutic region at the distal portion, the therapeutic region containing a therapeutic agent configured to prevent or reduce colonization of the substance by a pathogen.
20 . The device of claim 13 , wherein the elongated member comprises one or more visual markings.